Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isolation and Characterization of ERBB Expressing Human Heart Progenitor Cells

NCT02820233 is registered in ClinicalTrials.gov with Douglas B. Sawyer as lead sponsor.

NCT NCT02820233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02820233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isolation and Characterization of ERBB Expressing Human Heart Progenitor Cells
Lead sponsor
Douglas B. Sawyer
Phase
Observational
Overall status
Recruiting
Start date
June 30, 2015
Completion date
June 30, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease, heart failure, vascular disease